Literature DB >> 16525550

Subtype selectivity and flexibility of ionotropic glutamate receptors upon antagonist ligand binding.

Ulla Pentikäinen1, Luca Settimo, Mark S Johnson, Olli T Pentikäinen.   

Abstract

The binding modes of a set of known ionotropic glutamate receptor antagonist-ligands have been studied using homology modeling, molecular docking, molecular dynamics (MD) simulations and ab initio quantum mechanical calculations. The core structure of the studied ligands is the decahydroisoquinoline ring, which has a carboxylic acid group at position three and different negatively-charged substituents (R) at position six. The binding affinities of these molecules have been reported earlier. From the current study, the carboxylate group of the decahydroisoquinoline ring hydrogen bonds with Arg485, the amino group with Pro478 and Thr480, and the negatively charged substituent R interacts with the positively charged N-terminus of helix-F. The subtype selectivity of these ligands seems to be strongly dependent on the amino acid at position 650 (GluR2: leucine, GluR5: valine), which affects the conformation of the ligand and ligand-receptor interactions, but depends considerably on the size of the R-group of the ligand. In addition, the MD simulations also revealed that the relative positions of the S1 and S2 domains can alter significantly showing different "closure" and "rotational movements" depending on the antagonist-ligand that is bound. Accordingly, molecular docking of antagonist ligands into static crystal structures cannot sufficiently explain ligand binding and subtype selectivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525550     DOI: 10.1039/b515111b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  6 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  Comparative virtual screening and novelty detection for NMDA-GlycineB antagonists.

Authors:  Bjoern A Krueger; Tanja Weil; Gisbert Schneider
Journal:  J Comput Aided Mol Des       Date:  2009-11-05       Impact factor: 3.686

3.  Novel analogs and stereoisomers of the marine toxin neodysiherbaine with specificity for kainate receptors.

Authors:  L Leanne Lash; James M Sanders; Nobuyuki Akiyama; Muneo Shoji; Pekka Postila; Olli T Pentikäinen; Makoto Sasaki; Ryuichi Sakai; Geoffrey T Swanson
Journal:  J Pharmacol Exp Ther       Date:  2007-11-21       Impact factor: 4.030

4.  Exploring kainate receptor pharmacology using molecular dynamics simulations.

Authors:  Pekka A Postila; Geoffrey T Swanson; Olli T Pentikäinen
Journal:  Neuropharmacology       Date:  2009-09-06       Impact factor: 5.250

5.  The GluN2B-Glu413Gly NMDA receptor variant arising from a de novo GRIN2B mutation promotes ligand-unbinding and domain opening.

Authors:  Gordon Wells; Hongjie Yuan; Miranda J McDaniel; Hirofumi Kusumoto; James P Snyder; Dennis C Liotta; Stephen F Traynelis
Journal:  Proteins       Date:  2018-10-05

6.  Structural mechanism of N-methyl-D-aspartate receptor type 1 partial agonism.

Authors:  Mikko Ylilauri; Olli T Pentikäinen
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.